Early research (Phase 1)Study completedNCT02635672What this trial is testingPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerWho this might be right forNeoplasms Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Looking for participantsNCT06745076What this trial is testingPersonalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin LymphomaWho this might be right forAdvanced Hodgkin LymphomaClassic Hodgkin LymphomaLugano Classification Stage III Hodgkin Lymphoma AJCC v8+1 more University of Washington 125
Early research (Phase 1)Ended earlyNCT06870487What this trial is testingLearn About the Study Medicine Called PF-08046032 in People With Advanced CancersWho this might be right forPeripheral T Cell LymphomaDiffuse Large B-cell LymphomaClassical Hodgkin Lymphoma+3 more Pfizer 6
Early research (Phase 1)Active Not RecruitingNCT03212404What this trial is testingPhase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersWho this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more Checkpoint Therapeutics, Inc. 272
Not applicableWithdrawnNCT06104878What this trial is testingA Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy AloneWho this might be right forHodgkin Lymphoma Takeda
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75